Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease

IMG-007 - ImageneBio

telazorlimab (ISB 830) - BioCryst Pharmaceuticals

Jonatan Tuncel* 1; Chongtian Guo 2; Kurinji Pandiyan 1; Ben Porter-Brown 1; Kristin Yarema 1

May 18, 2026